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1, 1NTKODUCTION 
The urokinasc-type plasminogcn sctivator (u-PA, EC 
3.4.21.31) is (? scrine prOt~iniW, which catalyses the 
conversion of plasminogcn to plasmin (EC 3.4.21.7), 
found in scvcral normal and pathological rissucs and in 
body fluids [l-3], Many data indicnoc that u-PA is in- 
volved in the directional extracellular proteolysis which 
may be required in cell migration, tissue destruction, in 
several normal and pathological processes such as in- 
flammatory reaction, invasive growth of trophoblasts 
and cancer cells [4,5]. 
The proenzymc is a single polypcptidc chain (SW-PA 
with an approximate M, of 5S kDa) containing 411 
amino acids organized in four domains: (1) an epidcr- 
mal growth factor (EGF) domain, spanning amino 
acids 5-45 with homology to EGF; (2) a ‘kringle’ do- 
main, from amino acids 46 to 135; (3) a connecting pep- 
tide domain from residues 136 to 158; (4) a serine pro- 
teinase domain, from amino acids 159 to 411, with 
associated enzymatic activity [1,3]. The activation of 
SW-PA to two chain u-PA (@u-PA, with an iVZr of 55 
kDa) is obtained by cleavage of the Lys-158-Ile-159 
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bond: this active tcu-PA consists of two polypeptidc 
chains, linked by a disulphide bridge between cystcine 
residues 148 and 279 (respectively located in the connec- 
ting peptidc and in the proteolytic domains). Additional 
cleavage in the connecting pcpride may originate an en- 
zymatically active 33 kDa tcu-PA. 
In this paper we present evidence of tyrosine 
phosphorylation of human u-PA (S5 and 33 kDa) 
purified from urines or produced in vitro and in vivo by 
human fibrosarcorna HT1080 tumor cells (55 kDa). 
2, MATERIALS AND METHODS 
2. I . hlorcrials 
HUIII~II urokinnse (EC 3,4.21.31) with specific activity of 92 719 
IU/mg was purchased from Scrva (Heidelberg, Ccrmnny), human 
Gluqtasrninogcn from Blopool (Urnen, Sweden). Oqhospho-DL- 
scrinc, O.phospho-DI_.thrconinc, O.phospho.DI,-tyrosinc and the 
low molecular weigh\ markers used as standard in etcctrophoresis 
were obtained from Sigma (St, Louis, MO, USA) and Amido black 
1OB was purchased from Merck (Darmstadt, Germany). The goat 
anti-human urokinnsc IgG fraction was purchased from Biopool 
(Umca, Sweden); the polyclonal affinity-puified anti-P-Tyr an- 
tibodics [6-R] were kindly provided by Prof. Comoglio (Torino, Ita- 
ly), and by Dr. Wang (San Diego, La Jolla, CA, USA); the mono- 
clonat anti-P-Tyr antibodies (MoAb) were obtained culturing the IGz 
hybridoma cells [9-l 1) purchased from ATCC (USA) with the per- 
mission of Dr, Frockelton (Providence, Rhode Island, USA). 
Alkaline phosphatase (AP)*conjugated rabbit anti-goat and goat anti, 
mouse I@, were obtained from Promega (W 15371 I, USA), as welt as 
the Nitrobtuetetrazolium (NBT) and S-bromo-4~chloro-3-indolyl- 
phosphate (BCIP) substrates. 
2.2. Prepararion of HT-1060 condirioned media 
Human fibrosarcoma cells (MT-1080, ATCC, CCL 121, Rockville, 
MD, USA) producing u-PA [l2], were grown in a 24-welt plate 
(Costar) up to confluency in growth medium (minimum essential 
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Zymourrrphy 0r pralrin5 was atrricd 011l wirh n pracetlws 
dcvrlcpcd by Calsmbi er al. [13], fhc prtxcinx wrr srp~~raw4 by 8% 
p&wrylnmidc gel clcFlrnphorrrir(PAOE) in Ihr prawcc of podium 
tledixyl nrilfatc (SDS) uridcr non-reducing contlilionr nnd elcc- 
trolranJferrrd an nitrecelluloxe sheetx (Scheichcr and Schilll, Gcr- 
many) accordinp to bnenrmli and Tawbin, rcxpce~ivcly [l&IS). After 
wnnsfcr the fihcrn wcrc ovcrluid omo csscin plr~ex containing Ipy/ml 
bf human plrsminogrn. The lysis bands, dcrrlnpetl nfw 24 h of in- 
cubMan PI 37% in a humidified armorphcrc, were phatographcd us- 
ing dark-field light, 
In immunabloWg experiments, af~cr transfer and sa~urntion, the 
filters were incubated overnight at room temperature with the first an- 
tibody which, depending on the cxpcrimcnts wcrc: godt rmrisu PA l#G 
(l:SOO), polyclonal nl’finity-purified anti-P-Tyr antibodirs (0.3 &nil) 
nnd I G2 monoclonnl anti+Tyr anribodicn (t :25), Afrcr washing, the 
liltcrr wwc incubntcd, with AP.conjugatcd rabbit anti-goat lgcj 
(I:lOOO) or &oat antimouse 1gCi (1:7500) awl ~lrc positive bnntls 
cvidcnccd will1 NUT and RCIP substrntcs (161. 
3. RESULTS 
3. I. Tyrosine phosphorylation of purified u-PA 
Aliquots of 3 and 1 ~6 of u-PA (Fig. 1, lanes I and 2), 
loaded in triplicate (A, B and C), and one of 0.02 ~16 (D) 
A 3 c 0 ---- 
Fig. 1, Tyrosine phosphorylation of purified human u-PA. Commer- 
cially available research grade u-PA, purified from human urines, 
was tested at 3 and 2 &track (lanes i and 2 respectively); after elcc- 
trotransfer to nitrocellulose filters these were stained with Amido 
black (panel A) and treated with polycional anti-u-PA anibodies 
(panel B) or monoclonal anti-P-Tyr antibodies (panel C); one aliquot 
(0.02 &track) was also tested in zymography (panel D). 
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in xexian 1, 
wcrc electrophoresed in $6 SDS-PAGE under non- 
reducing condirions. After clectrotransfer on 
nitroccllulose filters, portions of the filter were Amido 
black-stained (pan4 A), immunorcacted with 
polyclonal anti-uPA IgG (panel 5) or with monoclonal 
anti-P-Tyr antibodies (panel C). Zymographic analysis 
of u-PA is reported in panel D. 
The 55 kDa stained protein band, also reacts with 
anti-u-PA antibodies and with anti-P-Tyr MoAb, Par- 
tially degraded, enzymatically active, 33 kDa u-PA also 
gives a positive response with anti-u-PA and anti- 
P-Tyr. 
As reported in Fig, 2, the posirivc 55 kDa band 
evidenced with anti-P-Tyr MoAb (lane 1) is suppressed 
when 20 mM P-Tyr is added at the first step of im- 
Fig. 3. Phosphorylated tyrosine residues in human u-PA secreted in 
vitro by human fibrosarcoma cells. The conditioned media of 
HT1080 cells, collected and prepared as described in section 2, was 
analyzed (30 PI/track) in immunoblotting against monoclonal anti-P- 
TYr or polyclonal anti-u-PA antibodies (lanes A 1 and 2, respectively) 
and in zymography (lane B). 
Lane B was overlayed cm egnr-cnscin plnsminagen 
platen for fhc enzymatic dcrecrion af U-PA activity 
whilr! lane A WBS divided infa two portions: one (lane A, 
I) immunoreaercd with anti-P-Tyr MoAb and ant (Inne 
A, 2) with anti-u-PA IgG, 
The results obtained indicnw that u*Ph secrc~ci by 
HT1080 cells is Tyr-phospharylntetL and if represenfs 
the main P-Tyr protein secreted in vitro by fhesc eells, 
The analysis was also extended TV tumors induced in 
nude mice by MT1080 cells. Nude mice, S.C. injected 
with HT-1080 cells, were sacrificed c?t differenr times 
starring from the apprarance of a dctccrablc tumor 
mass. The fumor was excised and the tumor extract 
analyscd. Fig. 4, as an cxamplc, reports the rcsuifs ob- 
taincd by rhc analysis of one tumor which, after 30 days 
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FiC, 4. Phosphorylated tyrosine residues in human u-PA present in 
tissue extracts of tumors induced in nude mice by HT-1080 cells. The 
tumor tissue extract (IO,5 &track), obtained as described in section 
2, was reacted in immunoblotting with anti-u-PA and with anti-P-Tyr 
antibodies (panels A and B, respectively, lanes I) and was analyzed 
also in zymography (panel A, lane 2); the same specimen was probed 
with anti-P-Tyr MoAb (panel C, lane 2) and with AP-conjugated goat 
anti-mouse antibodies as control of the positi*ve bands recognized by 
the second antibody (panel C, lane 1); moreover the specificity of the 
monoclonal anti-P-Tyr antibody was tested probing the blots in the 
presence of 20 mM P-Tyr, P.Treo, P-Ser (lanes 3, 4 and 5, respec- 
tively). 
AH thesednm, indicate that fhe u-PA present in fissuc 
~XC~RC~S. of PlflOHl tumors, induced in nude mice, eon- 
fains P-Tyr residues and that u-PA is rhe main fyroainc- 
phosphorylared profein defectable, 
Protein phosphorylefion is one of the major general 
mechanisms by which intracellular events in marn- 
malian tissues are controlled by externnl physiological 
stimuli; dit’fercnr cellulnr functions arc controlled by a 
network of regulatory pathways mediafed by 
phosphorylation and dcphosphorylation. All prorein 
kinases discovered prior to 1980 were known to 
phosphorylate proteins on scrinc or thrconine residues. 
In 1980 Hunter and Sefton [17] showed that the protein 
product of the src oncogenc was a tyrosine kinase and 
in the subscqucnt years the products of many other on- 
cogcrzcs and the receptors of several polypcptide growth 
factors were found to possess uch activity [ 18). The 
development of specific anti P-Tyr polyclonal and 
monoclonal antibodies [6,7,9,19] has helped to over- 
come the difficulty in distinguishing Tyr- 
phosphorylation from P-Scr or P-Trco residues becom- 
ing a powerful tool to identify protein tyrosine kinases 
with autocatalytic activity and cellular protein 
substrates. It is known that the dynamic equilibrium 
between the phosphorylation and the dephosphoryla- 
tion [20] of proteins and/or enzymes may turn on or off 
signals in the cell and that hormone regulated enzymes 
can be post-translationally modified by phosphoryla- 
tion [21]. Modulation of u-PA activity is part of the 
cellular response to growth stimuli and increased pro- 
duction of u-PA is associated with many spontaneous 
tumors and also with tumor virus-transformed cells 
[4,22,23]. The recent preliminary report, by 
Mastronicola et al. 1241, of serinc p!losphorylation of u- 
PA suggests that this enzyme might modulate its activi- 
ty via phosphorylation. In this paper we report that 
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purilicrt hun~n MA nnd u*Pk produecd in vitro by 
HTlO88 eel14 and scrrctrd into rhc erxndirioncd 
medium, 85 well s10 rhe are present in rinzuc eXtraaX of 
tumors induced in nudr mice by ~Tl~~~~~l~$, shows P- 
Tyr residues recognlncci by anti P*Tyr nnribadia in- 
hibited by P-Tyr but not by P-&v or P-Tren. The 
rcsulta obt&xd also show that, in vitro or in viva, the 
only phcsphorylared ryrosine protein dctcctablc with 
our nsswy system is u-PA* Since it is known thnr the u- 
PA secreted under acrum-free rolnditinns by PtT1088 
cells consists for 90% Of sru@A [25], our results in- 
dienre that pro-u-PA is Tyr-phasphsrylnted, An already 
shown [12], the u.PA nctiviry evidcnccd in the culrurc 
mcdin of HT1086 cclln nnd deteotnblc in zymogrnphy ie 
due KO the ncrivntisn of rhe proenzymes in rhc aany 
plate. The positive 33 kDn bnnd cvidcnred with purified 
u-PA also showx that W-PA is Tyr.phosphorylntcd too 
and in particulnr in the proteolytic clomnin lacared in 
the B chain [ 11 of the molcculc; we cnnnot exclude Tyr- 
phospharylation of the A chain of the 55 ki3a u-PA. 
Work is in progress to verify the possible involvcmrnr 
of phosphorylnrion in rhc modularion of the enzymatic 
activity, 
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